Applications1 year ago
Biocon launches Ustekinumab biosimilar Yesintek in US market
MUMBAI: Biocon Biologics Ltd has announced the US launch of Yesintek (ustekinumab-kfce), one of the first biosimilars to Janssen’s Stelara® to enter the American market. The...
